Data cannot be shared publicly because this was not envisioned at the time of applying for the Ethics Committee approval. In particular, the Confidentiality Assurances section of the approved IRB Application had the following statement: \"Only the study investigators will have an access to the obtained information as well as the database.\" The AUA IRB operates under Federalwide Assurance (FWA) for the Protection of Human Subjects Number: FWA00001683. Data requests can be sent to Ms. Varduhi Hayrumyan, the AUA Institutional Review Board's Human Protections Administrator,. E-mail: <auairb@aua.am>. Information on the AUA IRB is available at <https://aua.am/aua-institutional-review-board-guidebook/>.

Introduction {#sec006}
============

Eastern Europe has the highest rates of smoking in Europe \[[@pone.0222813.ref001]\] but affordable smoking cessation interventions are lacking in this region \[[@pone.0222813.ref002]\]. Treatments that combine physician counselling and pharmacotherapy increase smoking cessation rates; such treatments are not just cost-effective, they are cost-saving \[[@pone.0222813.ref003]\]. Trained physicians are about twice as likely to offer help to patients who smoke as non-trained physicians, and a lack of training or inadequate training is one of the major obstacles for consistent and effective tobacco dependence treatment \[[@pone.0222813.ref004]\]. The existence of smoking cessation training programs is strongly associated with country income category, to the advantage of high-income countries: only 1% of health care providers trained in smoking cessation in 2007 were working in low-income countries \[[@pone.0222813.ref002]\]. Another obstacle to the provision of quitting assistance is health care providers' smoking status; physicians who smoke are less likely to advise patients to quit smoking \[[@pone.0222813.ref005]\]. The majority of European medical students recognize the need for smoking cessation training, but up to 40% of medical students in Eastern European countries use tobacco products \[[@pone.0222813.ref006]\].

Many postgraduate programs for physicians' smoking cessation training are available in Europe; however, their effectiveness in changing provider practices and patient smoking outcomes is not adequately evaluated. Most often, these courses cover brief intervention, pharmacotherapy, motivational interviewing skills and the stages of behavioural change \[[@pone.0222813.ref007]\]. One such scheme, an innovative postgraduate training program implemented in teaching hospitals in Switzerland, was shown to improve both physician counselling skills and patient-related outcomes \[[@pone.0222813.ref003]\]. The effects of this program were explained by the combined impact of active learning methods (as opposed to traditional top-down teaching), the availability of trained faculty and framing the smoking problem in the local (Swiss) context \[[@pone.0222813.ref008]\]. We recently applied this well-established training program in Armenia, a country in Eastern Europe where 50.9% of men and 3.2% of women are tobacco smokers \[[@pone.0222813.ref001]\]. In this study, our aim was to assess the feasibility of the training intervention and its effects on the smoking cessation counselling skills of medical residents in Yerevan, Armenia.

Materials and methods {#sec007}
=====================

Study setting {#sec008}
-------------

This training course was conducted at the American University of Armenia (AUA) in Yerevan. The study participants were medical residents of Yerevan State Medical University (YSMU).

Data collection and instruments {#sec009}
-------------------------------

Data for this study were collected from medical residents from May 2015 to January 2016. Data collection included an evaluation survey at the completion of the training course, and a self-assessment of smoking cessation counselling skills before and 6 months after the training course, to allow participants time to practice the skills acquired. All surveys were self-administered, anonymous, and collected by a third party in the absence of the course instructor. The questionnaires validated in previous studies \[[@pone.0222813.ref008]\] were translated from English in Armenian. The questionnaire that evaluated the cessation counselling course was administered immediately after the training and included 10 items on the course objectives (three-point rating scale), five items to assess the course duration and seven items on the overall quality of the course (five-point Likert scale). The respondents also answered two open-ended questions regarding the strengths and weaknesses of the training course.

The questionnaire that evaluated the medical residents' smoking cessation counselling activities contained 23 items covering tobacco dependence assessment, smoking cessation counselling strategies, and pharmacological treatment. The structured questionnaire had four-point Likert-type response options to assess the residents' use of counselling strategies before and 6 months after the training, including the "5 As": asking about tobacco use, advising every smoker to quit, assessing their willingness to quit, assisting in making a quit attempt and arranging a follow-up visit \[[@pone.0222813.ref009]\], among others.

Analysis {#sec010}
--------

Given the purpose of this study was to examine the feasibility of the intervention we aimed to recruit a sample size of 40 participants. A non-parametric Mann-Whitney test was used to assess pre-post changes in physicians' counselling skills measured on an ordinal scale (Likert-type questions). Descriptive statistics were calculated for the overall assessment of the course. Statistical significance was defined at p\<0.05.

Recruitment {#sec011}
-----------

The Faculty of Postgraduate and Continuing Medical Education contacted in May-June 2015 a selected sample of medical residents in different years of study at Yerevan State Medical University and invited to the training. The inclusion criteria were the specialization in cardiology, gastroenterology and pulmonology as it was assumed that these specialists were more likely to devote time to smoking cessation counselling. Residents in surgery, gynaecology, emergency medicine and other narrow specialties were not invited. No other restrictions were applied in the recruitment process. All residents meeting the inclusion criteria were invited to the training.

Training materials {#sec012}
------------------

The original Swiss materials, including trainer's manual, case scenarios, slides, video-taped counselling sessions, and patient brochures were translated from French into Armenian by professional services. The Armenian lead co-investigator (first author) reviewed the translated materials for the medical terminology and the relevance to local context and added the data on smoking epidemics in Armenia. In addition, two teaching faculty members of the YSMU Department of Family Medicine reviewed and adjusted the case scenarios and the patient brochures for cultural appropriateness.

Standardized patient training {#sec013}
-----------------------------

Three professional actors were recruited and trained as *standardised patients* using written scenarios featuring various patient profiles across a range of socio-demographic (age, gender, education, marital and employment status) and smoker's characteristics (motivation to quit, addiction severity, etc.).

Training {#sec014}
--------

A two-day small-group training workshop for medical residents was conducted at the American University of Armenia and included 4-hour sessions scheduled to allow practice between the sessions. In the first session, the trainer briefly introduced the concepts of behaviour change stages in tobacco addiction, followed by a demonstration of video-materials and role plays. The trainees were asked to complete observation checklists to assess the videotaped cases and the role plays. The assessment results were discussed in groups of 3--4 participants and then in a classroom, with a feedback from the trainer. The second day session included a brief presentation on pharmacological treatment options and practicing with standardized patients. Residents received patient education brochures after the training.

Results {#sec015}
=======

Participants' characteristics {#sec016}
-----------------------------

Of 48 physicians who were invited, 37 attended the training course (77%) and 36 returned the demographic forms. Of these, the majority were female (n = 27, 75%), aged 20--29 years (n = 32, 89%), and non-smokers (n = 30, 83%). Cardiology and gastroenterology were the two most common fields of specialization. Six of nine male physicians were current smokers. Ten physicians, including four females, reported use of other tobacco products, mostly narghile (waterpipe) and cigars ([Table 1](#pone.0222813.t001){ref-type="table"}).

10.1371/journal.pone.0222813.t001

###### Participants' characteristics at baseline (n = 36).

![](pone.0222813.t001){#pone.0222813.t001g}

  Demographic characteristics & smoking status   Categories       \% (N)
  ---------------------------------------------- ---------------- -----------
  Gender                                         Male             25.0 (9)
  Female                                         75.0 (27)        
  Age, years                                     20--29           88.9 (32)
  30--39                                         8.3 (3)          
  40--49                                         2.8 (1)          
  Marital status                                 Single           69.4 (25)
  Married                                        27.8 (10)        
  Divorced/separated                             2.8 (1)          
  Specialty                                      Cardiology       44.4 (16)
  Gastroenterology                               36.1(13)         
  Internal medicine                              11.1 (4)         
  Pulmonology                                    5.6 (2)          
  Dentistry                                      2.8 (1)          
  Smoking status                                 Current smoker   16.7 (6)
  Ex-smoker                                      0 (0)            
  Never-smoker                                   83.3 (30)        
  Use of other tobacco products                  Narghile         30.0 (3)
  Cigar                                          30.0 (3)         
  Narghile +cigar                                20.0 (2)         
  Narghile + e-cigarette                         10.0 (1)         
  Narghile + cigar + e-cigarette                 10.0 (1)         

Training course evaluation {#sec017}
--------------------------

Of 37 trainees, 28 (76%) returned the course evaluation questionnaire. The proportion of participants who believed that the course "completely achieved" its learning objectives varied in a range of 64%-96% depending on the specific objective. The highest level of agreement was on the item "Understanding the physician's role in smoking cessation" followed by "Advise smokers with strategies that match their motivation to quit". Objectives on prescribing medications and increased self-efficacy in helping smokers to quit were met to a lesser extent ([Fig 1](#pone.0222813.g001){ref-type="fig"}). The trainees highly appreciated the acquired knowledge and communicating skills. A few found that counselling strategies and video materials could be more relevant to local context.

![Achievement of the training objectives.\
Each axis of the spider graph represents one of the objectives. The scale on each axis represents the level of achievement on a Likert-like scale (not achieved at all, partially achieved, completely achieved).](pone.0222813.g001){#pone.0222813.g001}

Smoking cessation counselling activities {#sec018}
----------------------------------------

Of 37 participants who completed the baseline self-assessment questionnaire on smoking cessation counselling skills, 32 (86%) answered the same questionnaire at the 6-month follow-up. Significant before-after differences were found on the six of seventeen individual items on counselling strategies ([Table 2](#pone.0222813.t002){ref-type="table"}). The strongest effects were observed on asking about the time to the first cigarette of the day, suggesting an appointment to discuss smoking, and providing self-help materials (all p≤0.001). No differences were found in self-reported medication prescription patterns, including cytisine and nicotine gum/patch.

10.1371/journal.pone.0222813.t002

###### Physicians' self-reported counselling activities before and after the training course.

![](pone.0222813.t002){#pone.0222813.t002g}

  Counselling strategy                                   Before % (n)(N = 37)   After % (n)(N = 32)   P[\*](#t002fn001){ref-type="table-fn"}-value                                                               
  ------------------------------------------------------ ---------------------- --------------------- ---------------------------------------------- ----------- ----------- ----------- ----------- ----------- -------------
  Ask if the patient smokes                              64.9 (24)              24.3 (9)              10.8 (4)                                       0.00 (0)    78.3 (25)   18.7 (6)    3.13 (1)    0.0 (0)     0.193
  Ask about number of cigarettes per day                 46.0 (17)              32.4 (12)             18.9 (7)                                       2.7 (1)     53.1 (17)   25.0 (17)   21.9 (7)    0.0 (0)     0.638
  Ask about time to first cigarette of the day           2.7 (1)                2.7 (1)               29.7 (11)                                      64.9 (24)   18.8 (6)    21.9 (7)    40.6 (13)   18.8 (6)    **\<0.001**
  Ask if patient smokes indoors at home                  0.00 (0)               10.8 (4)              29.7 (11)                                      59.5 (22)   15.6 (5)    12.5 (4)    46.9 (15)   25.0 (8)    **0.003**
  Ask if patient intends to stop smoking                 40.5 (15)              40.5 (15)             15.2 (6)                                       2.7 (1)     59.4 (19)   37.5 (12)   3.1 (1)     0.00 (0)    0.052
  Advise reducing the number of daily cigarettes         61.1 (22)              22.2 (8)              11.1 (4)                                       5.6 (2)     56.3 (18)   25.0 (8)    12.5 (4)    6.3 (2)     0.670
  Advise stopping smoking abruptly                       73.0 (27)              13.5 (5)              10.8 (4)                                       2.7 (1)     50.0 (16)   28.1 (9)    21.9 (7)    0.00 (0)    0.076
  Discuss the health risks of smoking                    48.7 (18)              40.5 (15)             8.1 (3)                                        2.7 (1)     46.9 (15)   28.1 (9)    25.0 (8)    0.00 (0)    0.525
  Discuss the benefits of smoking cessation              46.0 (17)              29.7 (11)             18.9 (7)                                       5.4 (2)     46.9 (15)   25.0 (8)    29.1(9)     0.00 (0)    0.990
  Discuss personal barriers to cessation                 13.5 (5)               29.7 (11)             37.8 (14)                                      18.9 (7)    15.6 (5)    28.1 (9)    43.8(14)    12.5 (4)    0.713
  Propose helping the patient quit                       22.2 (8)               8.3 (3)               27.8 (10)                                      41.7 (15)   28.1 (9)    25.0 (8)    37.5 (12)   9.4 (3)     **0.017**
  Advise on behavioural "tricks"                         10.8 (4)               13.5 (5)              27.0 (10)                                      48.7 (18)   9.4 (3)     25.0 (8)    46.9 (15)   18.8 (6)    **0.048**
  Give practical advice to prevent relapse               2.7 (1)                35.1 (13)             27.0 (10)                                      35.1 (13)   12.5 (4)    28.1 (9)    46.9 (15)   12.5 (4)    0.144
  Give self-help materials                               2.7 (1)                10.8 (4)              40.5 (15)                                      46.0 (17)   9.4 (3)     43.8 (14)   40.6 (13)   6.3 (2)     **\<0.001**
  Propose an appointment to discuss smoking              0.00 (0)               2.7 (1)               16.2 (6)                                       81.1 (30)   6.3 (2)     12.5 (4)    37.5 (12)   43.8 (14)   **0.001**
  Refer patient to other specialists                     0.00 (0)               5.6 (2)               19.4 (7)                                       75.0 (27)   3.1 (1)     6.3 (2)     31.3 (10)   59.4 (19)   0.171
  Suggest setting a specific date for quitting smoking   5.4 (2)                16.2 (6)              10.8 (4)                                       67.6 (25)   12.5 (4)    9.4 (3)     37.5 (12    40.6 (13)   0.074
  Prescribe cytisine (Tabex^®^)                          2.7 (1)                2.7 (1)               10.8 (4)                                       83.8 (31)   0.00 (0)    9.4 (3)     28.1 (9)    62.5 (20)   0.057
  Prescribe NRT (gum)                                    0.00 (0)               0.00 (0)              24.3 (9)                                       75.7 (28)   0.00 (0)    9.4 (3)     28.1 (9)    62.5 (20)   0.170
  Prescribe NRT (patch)                                  0.00 (0)               2.8 (1)               8.3 (3)                                        88.9 (32)   0.00 (0)    0.00 (0)    28.1 (9)    71.9 (23)   0.092
  Prescribe any medication (patch or gum or cytisine)    2.7 (1)                5.4 (2)               24.3 (9)                                       67.6 (25)   0.00 (0)    12.5 (4)    34.4 (11)   53.1 (17)   0.237

\*P-value, Mann-Whitney test

Discussion {#sec019}
==========

In this study, we assessed the feasibility of an innovative smoking cessation training course for medical residents in Armenia. Most participants agreed that the training met its objectives to build the smoking cessation counselling skills, was understandable and acceptable. The strongest effects of the training were related to reconsidering the professional role in helping patients to quit and to learning to advise according to patient motivation to quit. In contrast, prescription of pharmacological treatment was less influenced by the training.

Six months after the course, the trained physicians were more likely to report adhering to evidence-based counselling strategies, including offering help, assessing level of dependence, advising on useful behavioural techniques, proposing an appointment to discuss smoking, and providing educational materials. Prescription of pharmacotherapy remained low at follow-up reflecting the course focus on counselling skills and, possibly, the external factors, including a low access to tobacco dependence medications in Armenia, of which only cytisine has been consistently available locally. In addition to the cost and availability of medications, patient characteristics and physician attitudes and beliefs about the effectiveness of medication and counselling may also influence prescribing patterns \[[@pone.0222813.ref010]\]. The barriers to using tobacco dependence medications need a further exploration in this local context.

In previous reports, the effects of smoking cessation counselling training for medical residents were mixed, from no effect to a significant improvement in some, but not all, counselling activities \[[@pone.0222813.ref011]\]. The training model developed in Swiss teaching hospitals (adapted and tested in this study) effectively improved the residents' counselling skills but not their prescribing practices \[[@pone.0222813.ref003]\]. Similarly, a Cochrane meta-analysis found a measurable effect of the training on professional performance and on patients' cessation rates but not on provision of tobacco dependence treatments, specifically nicotine replacement therapy \[[@pone.0222813.ref012]\]. This Cochrane review was, however, based on studies performed in high-income countries such as the US, UK, and Switzerland.

Our study adds to the scarce evidence on the medical residents' smoking cessation training in Eastern Europe, a region with high smoking rates. To our knowledge, this is the first attempt to apply active learning methods, including standardized patients, to train physicians on tobacco dependence treatment and counselling in post-soviet countries. The ample follow-up period, the high response to the follow-up survey, the use of anonymous and validated questionnaires, and the focus on physician behaviour (vs. knowledge and attitude) are the advantages of the study. The study assessed only self-reported cessation counselling activities, as objective verification was not feasible in this context. Focusing on physician behaviour rather than both physician and patient-related outcomes is another limitation of this feasibility study. Besides, the participants represented only selected fields of specialization whereas other specialists may have a different level of interest in smoking cessation counselling training. No control group was used in this feasibility study with a pre-post design; therefore, the effectiveness of the training program cannot be determined.

Future studies will aim to evaluate the effectiveness of the training model in changing provider and patient related outcomes and to explore the ways to further improve physician counselling and prescribing skills to reach out to the smoker patients in restricted-resource settings.

Ethics approval {#sec020}
===============

Approval for the study was obtained from the Institutional Research Board (IRB) of the American University of Armenia (AUA-2014-027). All study participants provided oral informed consent before entering the study.
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Future studies will aim to evaluate the effectiveness of the training model in changing provider and patient related outcomes and to explore the ways to further improve physician counselling and prescribing skills to reach out to the smoker patients in restricted-resource settings."

4\. Please correct your reference to \"p=0.000\" to \"p\<0.001\" or as similarly appropriate, as p values cannot equal zero.

Response: Done.

Responses to the Reviewer's comments

Reviewer's comments:

The revised version of this manuscript addresses the previous issues raised. Below are some minor additional suggestions.

1\. In the discussion could consider acknowledging that the design was a pre-post design for this feasibility study and given that there was no control group the effectiveness of the training program cannot be determined.

Response: Thank you for your suggestion. We have added a clear statement on this important study limitation.

"No control group was used in this feasibility study with a pre-post design; therefore, the effectiveness of the training program cannot be determined".

2\. In the analysis section could consider rephrasing the first sentence to \"Given the purpose of this study was to examine feasibility we aimed to recruit a sample size of 40 participants.\"

Response: The justification for the study sample size was re-phrased as suggested.

"Given the purpose of this study was to examine the feasibility of the intervention we aimed to recruit a sample size of 40 participants."

Other points: A legend was added in the Figure 1 as requested.
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Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.
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If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Conor Gilligan

Academic Editor
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Thank you for carefully addressing the comments raised about your paper. The paper reads well and makes an interesting and worthwhile contribution to the literature.
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